EUVIMEDEUVIMED entdecken
Crossref

Surface Modification of Islets With L-DOPA–KF7 Enhances Islet Survival by Inhibiting IBMIR in Intrahepatic Islet Transplantation

Daopeng Yang iD, Bin Qiao, Fang Bai, Jinliang Duan, Haibin Ji, Xue Ma, Zepeng Lin, Yibo Hou, Xiaoshun He, Xiaofeng Zhu, Bowen Zhuang, Xiaoyan Xie und 1 weitere

Diabetes · 2025

DOI: 10.2337/db24-1033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Daopeng Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Islets of Langerhans, Levodopa, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong province of China, Guangzhou Key Research and Development Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic islet transplantation is followed by islet loss due to the instant blood-mediated inflammatory response (IBMIR) in which platelet activation plays a key role. The KEATSTF-fragment (KF7), a newly discovered platelet inhibitor that interferes with the formation of the 14-3-3ζ–c-Src–integrin-β3 complex, holds significant potential in inhibiting IBMIR without causing significant bleeding. This study introduces a novel surface modification technique using 3,4-dihydroxy-l-phenylalanine (L-DOPA) conjugated with KF7 to enhance the engraftment of transplanted islets in a syngeneic marginal mass model. KF7 loaded with L-DOPA (L-DOPA–KF7) formed a protective coating on the surface of islets without interfering with their viability and functionality. Islets coated with L-DOPA–KF7 restored normoglycemia in diabetic mice, and survival time was significantly longer compared with the control group. Transplantation of L-DOPA–KF7–coated islets was associated with reduced blood clot formation and decreased infiltration of CD11b+ cells and platelets. In conclusion, a composite L-DOPA–KF7 coating significantly prolongs the survival of transplanted islets by providing a robust IBMIR isolation barrier, thereby enhancing the overall success of islet transplantation in preclinical models. Article Highlights KEATSTF-fragment (KF7), an inhibitor of 14-3-3ζ–c-Src–integrin-β3 complex, effectively suppresses the instant blood-mediated inflammatory response by reducing thrombosis without increasing the risk of bleeding. The dopamine precursor 3,4-dihydroxy-l-phenylalanine (L-DOPA) can simply bind to the surface of islets without affecting cell viability or functionality, thus providing potential opportunities for clinical applications. A composite L-DOPA–KF7 coating effectively inhibited infiltration of platelets and CD11+ cells, thereby enhancing the efficacy of islet transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of Langerhans TransplantationIslets of LangerhansLevodopaDiabetes Mellitus, ExperimentalInflammationAnimalsMiceMaleGraft SurvivalMice, Inbred C57BLPlatelet Activation

Substanzen

Levodopa

Autor:innen und Institutionen

  • Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Organ Medicine, Guangzhou, China.
  • Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), Guangzhou, China.
  • Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Daopeng Yang

Förderung

  • Natural Science Foundation of Guangdong province of China
  • Guangzhou Key Research and Development Program
  • National Natural Science Foundation of China

Zitieren

APA

Yang, D., Qiao, B., Bai, F., Duan, J., Ji, H., Ma, X., Lin, Z., Hou, Y., He, X., Zhu, X., Zhuang, B., Xie, X., & Hu, A. (2025). Surface Modification of Islets With L-DOPA–KF7 Enhances Islet Survival by Inhibiting IBMIR in Intrahepatic Islet Transplantation. Diabetes. https://doi.org/10.2337/db24-1033

Vancouver

Yang D, Qiao B, Bai F, Duan J, Ji H, Ma X, et al. Surface Modification of Islets With L-DOPA–KF7 Enhances Islet Survival by Inhibiting IBMIR in Intrahepatic Islet Transplantation. Diabetes. 2025. doi:10.2337/db24-1033

BibTeX
@article{Yang2025,
  author = {Yang, Daopeng and Qiao, Bin and Bai, Fang and Duan, Jinliang and Ji, Haibin and Ma, Xue and Lin, Zepeng and Hou, Yibo and He, Xiaoshun and Zhu, Xiaofeng and Zhuang, Bowen and Xie, Xiaoyan and Hu, Anbin},
  title = {Surface Modification of Islets With L-DOPA–KF7 Enhances Islet Survival by Inhibiting IBMIR in Intrahepatic Islet Transplantation},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-1033}
}
Kostenlos starten →